Back to Authors

Reichert, Zachery Roger

Mayo Clinic

From the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda (A.B.A., N.S., S.N., L.L., L.C.), the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.H.-C.), and the Investigational Drug Bran

Citations 1

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine | September 15, 2024 | Volume: 392 | Issue: 1 | Pages: 45-55

10.1056/nejmoa2401726 | PMID 39282902